Literature DB >> 22711098

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab.

Maria Giuseppina Brizi, Mauro Galeazzi, Orso Maria Lucherini, Luca Cantarini, Rolando Cimaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22711098     DOI： 10.7326/0003-4819-156-12-201206190-00027

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  23 in total

Review 1.  [Translational research in pediatric rheumatology. Current research approaches to the innate immune system].

Authors:  K Lippitz; J Waldkirch; C Kessel; G Varga; D Foell
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

Review 2.  Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Authors:  Francesco La Torre; Maurizio Muratore; Antonio Vitale; Fulvio Moramarco; Laura Quarta; Luca Cantarini
Journal:  Rheumatol Int       Date:  2015-06-06       Impact factor: 2.631

3.  Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.

Authors:  Giuseppe Lopalco; Donato Rigante; Antonio Vitale; Bruno Frediani; Florenzo Iannone; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

Review 4.  Tumor necrosis factor-associated periodic syndrome in adults.

Authors:  Sharika Gopakumar Menon; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-09-23       Impact factor: 2.631

Review 5.  Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Authors:  Stefano Gentileschi; Donato Rigante; Antonio Vitale; Jurgen Sota; Bruno Frediani; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

Review 6.  Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.

Authors:  Hanne Van Gorp; Nina Van Opdenbosch; Mohamed Lamkanfi
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-01-02       Impact factor: 10.005

Review 7.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

Review 8.  Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Giacomo Emmi; Luisa Costa; Elena Silvestri; Laura Andreozzi; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

Review 9.  Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.

Authors:  Marco Cattalini; Martina Soliani; Giuseppe Lopalco; Donato Rigante; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2016-05-25       Impact factor: 3.397

Review 10.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.